It has been reported that LAPTM4B protein is significantly up-regulated in a wide variety of cancers including hepatocellular carcinoma, extra-hepatic cholangiocarcinoma, breast cancer, endometrial carcinoma, cervival carcinoma and ovarian cancer as well as gallbladder carcinoma. Here, LAPTM4B is linked to gallbladder carcinoma.